Camelia Dobrea

434 total citations
55 papers, 289 citations indexed

About

Camelia Dobrea is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Camelia Dobrea has authored 55 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 19 papers in Pathology and Forensic Medicine and 16 papers in Oncology. Recurrent topics in Camelia Dobrea's work include Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers). Camelia Dobrea is often cited by papers focused on Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers). Camelia Dobrea collaborates with scholars based in Romania, United States and United Kingdom. Camelia Dobrea's co-authors include Amelia Maria Găman, Carmen Ardeleanu, Irinel Popescu, Laura Necula, Radu Albulescu, Coralia Bleoţu, Valentina Uscătescu, Simona Dima, Cristiana Tănase and Ilie‐Cosmin Stancu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Orphanet Journal of Rare Diseases and Translational research.

In The Last Decade

Camelia Dobrea

50 papers receiving 278 citations

Peers

Camelia Dobrea

GENET

SURGE

PFM

HEPAT

Eléna Foïs France

Marie Deschaseaux France

Ji Hyun Kwon South Korea

Renée Zon Filippi Brazil

Elisa Carraro Italy

Chik Hong Kuick Singapore

Alessandra Viglio Italy

Anna Cariello Italy

Paolo Incardona Italy

Ho Jin Shin South Korea

Eléna Foïs France

Camelia Dobrea

160 ×1.7

GENET

85 ×1.0

SURGE

132 ×1.7

PFM

95 ×1.5

83 ×1.4

HEPAT

Citations per year, relative to Camelia Dobrea Camelia Dobrea (= 1×) peers Eléna Foïs

Countries citing papers authored by Camelia Dobrea

Since Specialization

Citations

This map shows the geographic impact of Camelia Dobrea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camelia Dobrea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camelia Dobrea more than expected).

Fields of papers citing papers by Camelia Dobrea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camelia Dobrea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camelia Dobrea. The network helps show where Camelia Dobrea may publish in the future.

Co-authorship network of co-authors of Camelia Dobrea

This figure shows the co-authorship network connecting the top 25 collaborators of Camelia Dobrea. A scholar is included among the top collaborators of Camelia Dobrea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camelia Dobrea. Camelia Dobrea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dobrea, Camelia, et al.. (2024). CML-602 Asciminib: A New Treatment Option in Patients With P-Loop Mutations: Case Report. Clinical Lymphoma Myeloma & Leukemia. 24. S376–S376.

Jurcuț, Ciprian, et al.. (2023). From clinic to echocardiography to microscope – the multimodal journey of a rare disease. SHILAP Revista de lepidopterología. 33(2). 72–77. 1 indexed citations

Moraru, Liliana, Camelia Dobrea, Andreea-Elena Scheau, et al.. (2022). Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina. 58(7). 874–874. 18 indexed citations

Bumbea, Horia, Viola Maria Popov, Ciprian Tomuleasa, et al.. (2022). Coexistence of Trisomy 8 and 13 in a Newly Diagnosed Patient With Diffuse Large B Cell Non-Hodgkin Lymphoma and Acute Myeloid Leukemia Secondary to Primary Myelofibrosis. Cureus. 14(2). e22217–e22217. 1 indexed citations

Dobrea, Camelia, et al.. (2021). Radiation response of soft‐tissue extramedullary plasmacytoma in multiple myeloma—A case report. SHILAP Revista de lepidopterología. 9(11). e05084–e05084. 3 indexed citations

Jurcuţ, Ruxandra, Sorina Bădeliță, Camelia Dobrea, et al.. (2020). Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population. Orphanet Journal of Rare Diseases. 15(1). 34–34. 12 indexed citations

Coriu, Daniel, et al.. (2019). Breast myeloid sarcoma after allogeneic stem cell transplantation for acute myelomonocytic leukemia - case report.. PubMed. 60(2). 707–711. 4 indexed citations

Vlădăreanu, Ana‐Maria, et al.. (2018). POEMS syndrome complicated with multiple ischemic vascular events: case report and review of literature. OncoTargets and Therapy. Volume 11. 6271–6276. 4 indexed citations

Vlădăreanu, Ana‐Maria, et al.. (2018). A Challenging Case of Kikuchi-Fujimoto Disease Associated with Systemic Lupus Erythematosus and Review of the Literature. SHILAP Revista de lepidopterología. 2018. 1–5. 16 indexed citations

10.

Dobrea, Camelia, et al.. (2015). A trans-theoretical approach to alcohol abuse profile in the general population of an islamic country - Mashhad, Iran.. PubMed. 8(1). 55–61. 5 indexed citations

11.

Mogoantă, Carmen Aurelia, et al.. (2015). Clinical and histological aspects with therapeutic implications in head and neck lymphomas.. PubMed. 56(2). 499–504. 6 indexed citations

12.

Iosif, Cristina, Rodica Bîrlă, Camelia Dobrea, et al.. (2013). Littoral cell angioma of the spleen--a surprising cause of anemia.. PubMed. 54(3 Suppl). 885–8. 7 indexed citations

13.

Tatic, Aurelia, et al.. (2013). Refractory anemia with ringed sideroblasts and thrombocytosis without JAK2 V617F mutation: report of three cases.. PubMed. 54(4). 1177–82.

14.

Găman, Amelia Maria, et al.. (2013). A case of non-Hodgkin lymphoma in a patient with chronic myeloid leukemia.. PubMed. 54(4). 1141–5. 7 indexed citations

15.

Coriu, Daniel, et al.. (2011). Bortezomib in systemic AL amyloidosis: a single center experience. Amyloid. 18(sup1). 148–150. 1 indexed citations

16.

Aramă, Victoria, Daniela Munteanu, Ioana D. Olaru, et al.. (2011). Reactivation of HBV infection in low grade lymphoma patient.. PubMed. 49(1). 67–73. 1 indexed citations

17.

Vlădăreanu, Ana‐Maria, et al.. (2010). The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results.. PubMed. 3(3). 320–9. 14 indexed citations

18.

Constantinescu, Gabriela, et al.. (2009). Hypolipemiant besides antileukemic effect of imatinib mesylate. Leukemia Research. 33(9). 1285–1287. 18 indexed citations

19.

Dima, Simona, Ilie‐Cosmin Stancu, Camelia Dobrea, et al.. (2009). In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors. Translational research. 154(3). 122–132. 63 indexed citations

20.

Mănuc, Mircea, et al.. (2008). Multicystic mesothelioma--a rare case of ascites: case report.. PubMed. 111(4). 895–900. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact